A Sunrise Industry for Southland

unsplash-image-sEWqMCemlVA.jpg

We aim to produce New Zealand’s most affordable high-quality cannabis-based medicines

We’re backed by science from New Zealand’s leading plant geneticists and pharmacologists, and we’re implementing a business model designed to give us the lowest cost-base in the industry.

Our aim is to provide a range of products that will allow the average medical cannabis user in New Zealand to access the safest and most affordable products available for less than the global average monthly spend.

mataura (1 of 1)-3.png

We grow high-quality non-THC medicinal cannabis in a controlled environment

Our plant genetics programme is already well established in our 400 m2 growing rooms, and we have plans to triple capacity within two years.

dgh (1 of 1)-2.png

We process hemp grown outdoors on Southland farms 

We’re partnering with Southland hemp growers to create new revenue streams and mitigate environmental impacts for Southland farms.

The Southland Industrial Hemp Bio-Economy is based on highly successful partnership programmes overseas.  You can read more about it here.

Mill (1 of 1)-36.png

We process for third party medicinal cannabis producers

Our large scale facility will remove one of the industry’s largest potential bottlenecks - the lack of processing capacity.   When fully operational, our facility will be able to process 20,000 kg of hemp flower per year for growers around New Zealand. 

mataura (1 of 1)-4.png

We supply high-quality cultivars for third party growers

Our genetics programme allows us to produce cloned seedlings at scale that are fit for New Zealand’s conditions and produce consistent medicinal-grade crops.  

With around 140 different cannabinoid compounds in each plant growing in different strengths depending on the cultivar, Southern Medicinal takes care to provide best-in-class plant varietals to meet the specific needs of our customers.